Nervous System Diseases

1,005 trials 421 recruiting

Filter these 1,005 trials by phase, country and sponsor.

Open in Search →

Biomarkers in clozapine-responding schizophrenia Recruiting

2024-515338-34-01 Schizophrenia 6 2024-10-10
FAST TRIAL Recruiting

2024-515507-18-00 Status epilepticus 5 2024-10-09
An extension study to find out if multiple treatment cycles of rozanolixizumab are safe and work in children with myasthenia gravis Recruiting

2022-502075-34-00 Generalized Myasthenia Gravis 5 2024-10-08
NeuroPET GBG 001 - Mapping pathogenic processes associated with the development of neurodegenerative disorders using novel neuroimaging moda… Recruiting

2024-513499-16-00 Neurodegenerative diseases 4 2024-10-08
A Phase 2a, dose-finding, randomized, double-blinded, placebo-controlled study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safet… Recruiting

2023-509613-37-01 Alzheimer's Disease 9 2024-10-08
Rituximab-induced remission in CIDP (ReCIX study) Recruiting

2024-512506-25-00 Chronic inflammatory demyelinating polyneuropathy (CIDP 5 2024-10-07
TestOsterone TreatmEnt on neuroprotection and Myelin repair in Relapsing Remitting Multiple Sclerosis (TOTEM-RRMS) Recruiting

2024-517845-14-00 Relapsing Remitting Multiple sclerosis 4 2024-10-03
(NFPET) 89Zr-Bevacizumab PET/CT imaging in NF2 patients Recruiting

2024-512860-75-00 NF2-related schwannomatosis 4 2024-10-01
Effect of xenon on brain injury, neurological outcome and survival in patients after aneurysmal subarachnoid hemorrhage Recruiting

2022-500596-32-00 Aneyrysmal subarachnoid hemorrhage needing ventilatory 4 2024-10-01
Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting

2024-514927-40-02 Chronic Subdural Hematoma 11 2024-10-01
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients w… Recruiting

2023-507064-39-00 generalized Myasthenia Gravis 5 2024-09-26
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 10 2024-09-25
GREAT; GRoningen Early-PD Ambroxol Treatment Trial Recruiting

2024-514976-41-00 Parkinson's disease 4 2024-09-23
Preincisional versus postincisional ultrasound-guided transversus abdominis plane (TAP) block comparative effect on chronic postsurgical pai… Recruiting

2024-513582-39-01 Chronic postsurgical pain after open inguinal hernia me 6 2024-09-20
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION582 in Patients with An… Recruiting

2024-512589-32-00 Angelman syndrome 7 2024-09-16
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s dise… Recruiting

2024-511110-21-00 Parkinson’s Disease 1 2024-09-09
HyperChrono Recruiting

2023-506663-33-00 IDIOPATHIC HYPERSOMNIA 4 2024-09-07
Involvement of the serotonergic system in the control of impulsivity in Tourette disorder : ARITEP Recruiting

2023-506370-13-00 Tourette disorder 4 2024-09-05
In vivo quantification of Hsp90 in the human brain in healthy aging and neurodegeneration using the novel PET radioligand [11C]HSP990 Recruiting

2023-510532-36-00 Alzheimer's Disease 1 2024-09-04
Efficacy and safety of Cerebrolysin for neurorecovery after moderate-severe traumatic brain injury Recruiting

2024-515591-12-00 Traumatic brain injury 11 2024-08-27
MODAFIMS: An open-label, single-center clinical trial to evaluate predictors of response to MODAFinil in the treatment of cognitive deficits… Recruiting

2022-501414-53-00 Multiple sclerosis 4 2024-08-21
Phase 1/2a study of ATX-01 in participants with DM1 Recruiting

2023-505363-37-00 Myotonic dystrophy type 1 (DM1) 1 2024-08-12
Darbepoetin for neonatal stroke Recruiting

2024-513042-12-01 Perinatal Arterial Ischemic Stroke (PAIS) 4 2024-08-08
ISCHEMIA Recruiting

2024-511679-14-00 subarachnoid hemorrhage 4 2024-08-08